Artwork

Indhold leveret af Molecule. Alt podcastindhold inklusive episoder, grafik og podcastbeskrivelser uploades og leveres direkte af Molecule eller deres podcastplatformspartner. Hvis du mener, at nogen bruger dit ophavsretligt beskyttede værk uden din tilladelse, kan du følge processen beskrevet her https://da.player.fm/legal.
Player FM - Podcast-app
Gå offline med appen Player FM !

Revolutionizing Drug Development for Rare Diseases Through AI | Alok Tayi

49:57
 
Del
 

Manage episode 430384522 series 3394247
Indhold leveret af Molecule. Alt podcastindhold inklusive episoder, grafik og podcastbeskrivelser uploades og leveres direkte af Molecule eller deres podcastplatformspartner. Hvis du mener, at nogen bruger dit ophavsretligt beskyttede værk uden din tilladelse, kan du følge processen beskrevet her https://da.player.fm/legal.

In this episode, we have the pleasure of hosting Alok Tayi, the co-founder of Vibe Bio.Vibe Bio is a life science company dedicated to investing in biotech firms, with a special focus on rare and overlooked diseases.

In this episode, Alok shares his personal story of how medical conditions in his family led to the creation of Vibe Bio, and how the company aims to identify diseases with unmet needs, leveraging AI to find medicines with the highest chances of providing cures.

We discuss the complexities of drug development, the advantages of DAOs as an organizational structure and common misconceptions within the Biopharma industry. Alok also shares his insights on the transformative role of AI in drug discovery, discussing its utilization, the methods used for training AI models, the issue of AI bias, and the current limitations and challenges faced in leveraging AI to advance drug development.

Feel free to navigate through any of the topics discussed in the podcast using the timestamps below.

___

⭐ Timestamps:

0:00 Intro

01:51 What led you to create Vibe

02:52 Diseases Vibe Focuses On

04:37 Complexities in Drug Development

7:49 Advantages of DAOs

12:00 Misconceptions in Academia & the Private Sector

16:53 Areas you’re willing to explore with more funding.

23:59 Utilizing AI tools in Drug Discovery

28:50 Bias in AI

32:54 AI Training Methods

36:58 Limits of AI in Drug Discovery

39:56 Implicit Knowledge in Drug Development

49:30 Outro

____

If you prefer listening to podcasts on audio apps, feel free to search for "The DeSci Podcast" on Spotify, Google Podcasts & Apple Podcasts. You'll also find all links to the podcast apps below.

If you want to join us on the show as a speaker or have guest ideas, please shoot us an mail at podcast@molecule.to

Special thanks to

Lea: https://twitter.com/lealeata

Alok: https://twitter.com/aloktayi

Learn more about Vibe Bio here: https://vibebio.com/

____

Let's connect:

Website: https://bit.ly/3d6nh2C

X: https://twitter.com/Molecule_dao

Discord: https://discord.com/invite/moleculedao

  continue reading

38 episoder

Artwork
iconDel
 
Manage episode 430384522 series 3394247
Indhold leveret af Molecule. Alt podcastindhold inklusive episoder, grafik og podcastbeskrivelser uploades og leveres direkte af Molecule eller deres podcastplatformspartner. Hvis du mener, at nogen bruger dit ophavsretligt beskyttede værk uden din tilladelse, kan du følge processen beskrevet her https://da.player.fm/legal.

In this episode, we have the pleasure of hosting Alok Tayi, the co-founder of Vibe Bio.Vibe Bio is a life science company dedicated to investing in biotech firms, with a special focus on rare and overlooked diseases.

In this episode, Alok shares his personal story of how medical conditions in his family led to the creation of Vibe Bio, and how the company aims to identify diseases with unmet needs, leveraging AI to find medicines with the highest chances of providing cures.

We discuss the complexities of drug development, the advantages of DAOs as an organizational structure and common misconceptions within the Biopharma industry. Alok also shares his insights on the transformative role of AI in drug discovery, discussing its utilization, the methods used for training AI models, the issue of AI bias, and the current limitations and challenges faced in leveraging AI to advance drug development.

Feel free to navigate through any of the topics discussed in the podcast using the timestamps below.

___

⭐ Timestamps:

0:00 Intro

01:51 What led you to create Vibe

02:52 Diseases Vibe Focuses On

04:37 Complexities in Drug Development

7:49 Advantages of DAOs

12:00 Misconceptions in Academia & the Private Sector

16:53 Areas you’re willing to explore with more funding.

23:59 Utilizing AI tools in Drug Discovery

28:50 Bias in AI

32:54 AI Training Methods

36:58 Limits of AI in Drug Discovery

39:56 Implicit Knowledge in Drug Development

49:30 Outro

____

If you prefer listening to podcasts on audio apps, feel free to search for "The DeSci Podcast" on Spotify, Google Podcasts & Apple Podcasts. You'll also find all links to the podcast apps below.

If you want to join us on the show as a speaker or have guest ideas, please shoot us an mail at podcast@molecule.to

Special thanks to

Lea: https://twitter.com/lealeata

Alok: https://twitter.com/aloktayi

Learn more about Vibe Bio here: https://vibebio.com/

____

Let's connect:

Website: https://bit.ly/3d6nh2C

X: https://twitter.com/Molecule_dao

Discord: https://discord.com/invite/moleculedao

  continue reading

38 episoder

Alle episoder

×
 
Loading …

Velkommen til Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Hurtig referencevejledning